Ketamine produces schizophrenia-like behavioral phenotypes in healthy people.
Introduction
Sp4 is a transcription factor that recognizes GC-rich sequences in the "CpG islands" around the promoters of many genes (Heisler et al, 2005) . In contrast to the Sp1 gene, Sp4 gene expression is restricted to neuronal cells in brain (Supp et al, 1996; Zhou et al, 2005) . Our previous studies found that Sp4 hypomorphic mice displayed several behavioral phenotypes relevant to psychiatric disorders (Zhou et al, 2005; Zhou et al, 2010; Zhou et al, 2007) . In humans, the SP4 gene was reported to be sporadically deleted in patients with schizophrenia (Tam et al, 2010; Zhou et al, 2010) , and the SP4 protein is reduced in the postmortem brains of bipolar patients (Pinacho et al, 2011) . Additionally, human genetic studies reported the association of SP4 gene with bipolar disorder, schizophrenia, and major depression (Greenwood et al, 2011; Shi et al, 2010; Shyn et al, 2009; Zhou et al, 2009 ). These studies suggest the Sp4 hypomorphic mice as a promising mouse genetic model for human psychiatric disorders.
Administration of ketamine, a noncompetitive NMDAR antagonist, induces behaviors that resemble several aspects of psychiatric disorders in healthy people (Krystal et al, 1994) .
Prolonged ketamine effects and exacerbation of symptoms were reported in schizophrenia patients (Holcomb et al, 2005; Lahti et al, 1995; Malhotra et al, 1997) . On the other hand, ketamine was recently found to act as a potent antidepressant that provides rapid relief to patients who are resistant to treatment with classical antidepressants (aan het Rot et al, 2010; Diazgranados et al, 2010; Price et al, 2009; Zarate et al, 2006) . It is unclear however, what genes and neurons are the key regulators of such responses to ketamine.
Sp4 hypomorphic mice have robust behavioral phenotypes such as deficient prepulse inhibition (PPI) and fear learning deficits, as well as hypersensitivity to ketamine-induced hyperlocomotion (Ji et al, 2013) . By taking advantage of a genetic rescue strategy used in the generation of Sp4 hypomorphic mice (Zhou et al, 2005) , we restored Sp4 expression in forebrain excitatory and GABAergic neurons, respectively. Behavioral deficits in PPI and fear conditioning as well as ketamine-induced hyperlocomotion were examined in the two different neuron-specific Sp4 rescue mice.
Materials and Methods

Mouse strains and breeding
The Sp4 hypomorphic mice were generated as previously described (Ji et al, 2013) . Emx1-Cre mouse line (stock number: 005628) and Dlx6a-Cre mouse line (stock number: 008199) were purchased from Jackson laboratory. Both lines were backcrossed with Black Swiss mice for more than 6 generations. Each Cre line was then bred with Sp4 heterozygous mice on Black Swiss background to obtain double heterozygous mice. The double heterozygous mice were finally bred with Sp4 heterozygous mice on 129S background to obtain F1 generation mice. All F1 Sp4 heterozygous mice were sacrificed, and the remaining four genotypes were used for molecular and behavioral analyses. Mice were housed in a climate-controlled animal colony with a reversed day/night cycle. Food (Harlan Teklab, Madison, WI) and water were available ad libitum, except during behavioral testing. Behavioral testing began at 3 month-old mice with prepulse inhibition, fear learning, and ketamine-induced locomotor activity with at least 2 weeks inbetween tests. All testing procedures were approved by the UCSD Animal Care and Use Committee (permit number: A3033-01) prior to the onset of the experiments. Mice were maintained in American Association for Accreditation of Laboratory Animal Care approved animal facilities at UCSD and local Veteran's Administration Hospital. These facilities meet all Federal and State requirements for animal care.
LacZ staining
Generation of neuron-specific Sp4 rescue mice
Mouse Emx1 (Briata et al, 1996) and Dlx5/6 (Robledo et al, 2002) expression are first detected at embryonic E9.5 and E8.5, respectively. Forebrain excitatory neurons originate from the Emx1 cell lineage (Gorski et al, 2002) , while forebrain GABAergic neurons are derived from Dlx5/6 cell lineage (Monory et al, 2006) . Since mouse Sp4 expression starts around E9.5 during embryogenesis (Supp et al, 1996) , the Cre driven by Emx1 and Dlx5/6 genes will restore Sp4 gene during the entire development of forebrain excitatory and GABAergic neurons, respectively. Both Emx1-Cre and Dlx6a-Cre mouse lines were purchased from Jackson laboratory and backcrossed with Black Swiss mice for more than 6 generations. Each Cre line was further bred with Black Swiss Sp4 heterozygous mice to generate double heterozygous mice that were finally bred with Sp4 heterozygous mice on 129S background to generate F1 mice ( Figure 1S ). In F1 Sp4 homozygous mice carrying either the Emx1-Cre or Dlx6a-Cre (Dlx5/6-Cre) gene, the nuclear LacZ cassette was excised to restore Sp4 expression in each cell lineage ( Figure 1 ). Consistent with previous reports on Emx1-Cre expression (Gorski et al, 2002) , introduction of Emx1-Cre into Sp4 heterozygous mice abolished LacZ staining in both cortical and hippocampal excitatory neurons ( Figure 1a ). Under higher magnification, many . RT-PCR confirmed restoration of rat Sp4 (rSp4, capped with a splicing acceptor) RNA expression in the cortex of (Sp4 Hypo/Hypo ; Emx1 +/+(Cre) ) rescue mice (Figure 2a ). A lower level of Sp4 RNA amplification from the striatum of the rescue mice likely comes from the restoration of Sp4 gene in a few striatal neurons derived from EMX1-Cre lineage (Cocas et al, 2009 ).
Western blot provided further validation of restoration of the Sp4 transcription factor in the cortex of the (Sp4 Hypo/Hypo ; Emx1 +/+(Cre) ) rescue mice ( Figure 2b ). Restoration of the Sp4 transcription factor was also confirmed in the striatum of (Sp4 Hypo/Hypo ; Tg(Dlx6a-Cre)) rescue mice ( Figure 2c ). An increased level of Sp4 protein was also detected from the cortex of GABAergic Sp4 rescue mice (Sp4 Hypo/Hypo ; Tg(Dlx6a-Cre)), because of restoration of Sp4 gene in cortical GABAergic neurons.
Behavioral characterization of the Emx1-Cre rescue mice
Deficits in PPI and fear learning as well as ketamine-induced hyperlocomotion were examined in the two different neuron-specific Sp4 rescue mice. In the Emx1-Cre rescue cohort, Sp4 hypomorphic mice showed significantly reduced PPI (F(1,80)=18.23, p < 0.0001) ( Figure   3a ), which was not rescued by restoration of the Sp4 gene in forebrain excitatory neurons in (Sp4 Hypo/Hypo ; Emx1 +/+(Cre) ) rescue mice (Sp4 X Emx1-Cre interaction, F(1,80)<1, ns). No sex effects were observed. Acquisition of fear learning was also reduced in Sp4 hypomorphic mice, which was not rescued by introduction of the Emx1-Cre gene (Figures S2a to S2c). We examined the locomotor response of these mice to ketamine (50 mg/kg) using video-tracking (VT) equipment. Before ketamine treatment, there was no significant Sp4 gene effect on distance traveled during habituation. After ketamine injection, Sp4 hypomorphic mice exhibited significantly more ketamine-induced hyperactivity compared to wiltype controls (Figure 3b ; Sp4 X ketamine interaction (F(1,79)= 12.97, p = 0.0006) on distance traveled). No Sp4 X Emx1-Cre X ketamine interaction was detected (F(1,79)<1, ns). The rescue mice (Sp4 Hypo/Hypo ; Emx1 +/+(Cre) ) displayed similar ketamine-induced hyperlocomotion as the (Sp4 Hypo/Hypo ; Emx1 +/+ ) Sp4 hypomorphic mice after ketamine injection, suggesting that there was no rescue of ketamine hypersensitivity.
Behavioral characterization of the Dlx6a-Cre rescue mice
In the Dlx6a-Cre rescue cohort, Sp4 hypomorphic mice exhibited reduced PPI (F(1,85)=9.73, p = 0.002) ( Figure 4a ). However, no Sp4 X Dlx6a-Cre interaction was detected (F(1,85)=1.38, ns) with the (Sp4 Hypo/Hypo ; Tg(Dlx6a-Cre)) rescue mice exhibiting similar PPI deficits to Sp4 hypomorphic mice. Additionally, the deficient fear learning in Sp4 hypomorphic mice was not rescued ( Figure S2d ). The response to ketamine was subsequently examined with the VT locomotion test. No significant Sp4 effect was observed during habituation. After ketamine injection, a significant Sp4 X ketamine interaction (F(1,85)=14.54, p < 0.001) was observed ( Figure 4b ). Interestingly, there was a significant Sp4 X Dlx6a-Cre X ketamine interaction (F(1,85)=7.44, p = 0.008). The rescue mice (Sp4 Hypo/Hypo ; Tg(Dlx6a-Cre)) displayed the same time-course pattern of locomotive hyperactivity as the control mice (Sp4 +/+ ; Tg(Dlx6a-Cre)) after ketamine injection, suggesting that restoration of Sp4 in forebrain GABAergic neurons is sufficient to rescue ketamine-induced hyperlocomotion in Sp4 hypomorphic mice.
Discussion
Genetic manipulations are powerful tools for disentangling the complex phenotypes.
Conventional and conditional gene-knockout strategies can determine whether a gene is necessary for a particular phenotype in a specific type of cells. Conditional rescue of a phenotype in knockout mice via restoration of the gene in only one specific cell type can determine whether the gene in that specific cell type is necessary and sufficient for controlling the phenotype. Many behaviors are complex and likely modulated by interactions between different types of neurons from different brain regions. Given that different types of neurons are involved in the modulation of behavior, it is not surprising that Sp4 gene restoration in only one specific type of neurons may not be sufficient to rescue behavioral phenotypes. Indeed, we failed to rescue deficient PPI and fear learning in Sp4 hypomorphic mice regardless of whether Sp4 gene was restored in forebrain excitatory neurons or GABAergic neurons. Importantly however, we found that restoration of the Sp4 gene in GABAergic neurons was sufficient to rescue ketamine-induced hyperlocomotion in the Sp4 hypomorphic mice.
Sp4 hypomorphic mice (Sp4 Hypo/Hypo ) from the Dlx6a-Cre rescue cohort displayed a prolonged response to ketamine than the wiltype control mice. However, Sp4 hypomorphic mice (Sp4 Hypo/Hypo ; Emx1 +/+ ) from the Emx1-Cre rescue cohort had a similar time-course response to ketamine with their sibling wiltype mice. The prolonged response to ketamine in the Sp4 hypomorphic mice from the Dlx6a-Cre rescue cohort is a more typical response of Sp4 hypomorphic mice according to our previous studies (Ji et al, 2013) . Why did the same dosage of ketamine not elicit a prolonged response to ketamine in the Sp4 hypomorphic mice from the Emx1-Cre rescue cohort? We speculate that there may be still subtle differences between the genetic backgrounds of the Emx1-Cre and Dlx6a-Cre mouse lines despite the fact that both Emx1-Cre and Dlx6a-Cre mouse lines were backcrossed for more than 6 generations. The genetic background of the Emx1-Cre rescue cohort may have been overall less sensitive to ketamine than that of the Dlx6a-Cre rescue cohort. We consider that different time-course responses to ketamine may be generated by differential ketamine sensitivities between mouse cohorts or different dosages of ketamine. Indeed, increasing dosages of ketamine produced more locomotor activity and prolonged responses (Irifune et al, 1991) . This observation may explain why the same dosage of ketamine generated different time-courses in the locomotor responses between the two different mouse cohorts. noncompetitive antagonist of NMDAR receptors that are present in both excitatory and GABAergic neurons in different brain regions. Both cortical GABAergic inhibitory and excitatory pyramidal neurons have been suggested to be the primary targets of NMDAR antagonists (Homayoun and Moghaddam, 2007; Moghaddam et al, 1997; Rotaru et al, 2011) . Our studies suggest that the mouse Sp4 gene is essential for forebrain GABAergic neurons to dampen locomotive responses to ketamine. Reduced Sp4 expression may impair the ability of GABAergic neurons to control locomotor hyperactivity in Sp4 hypomorphic mice after ketamine injection (Ji et al, 2013) . In contrast, the Sp4 gene expression appears dispensable in excitatory neurons in controlling locomotor response to ketamine. Since the genetic restoration of the Sp4 gene in Dlx6a-Cre lineage cells starts from early embryogenesis, our studies cannot differentiate whether altered development (if there is) and/or function of forebrain GABAergic neurons are responsible for ketamine hypersensitivity in Sp4 hypomorphic mice. Although we did not find gross abnormalities in the brains of Sp4 hypomorphic mice (Ji et al, 2013; Zhou et al, 2005) , we cannot rule out subtle structural alterations in GABAergic neurons. As for molecular mechanisms, NMDAR has been proposed as the primary target of ketamine.
Nmdar1 protein, but not mRNA, was down-regulated in the brains of Sp4 hypomorphic mice (Sun et al, 2015; Zhou et al, 2010) . Those findings however, came from mouse brain tissue that contained different types of neurons and glial cells, and hence do not necessarily exclude the Nmdr1 gene as a direct target of the Sp4 transcription factor in a small group of specific neurons. There is still a possibility that the Sp4 transcription factor may directly regulate mRNA expression of Nmdar1 gene in some forebrain GABAergic neurons (Krainc et al, 1998) .
Forebrain GABAergic neurons consist of striatal neurons and different cortical GABAergic neurons, it remains to be investigated which subset of GABAergic neurons is responsible for the rescue effects. Investigation of molecular mechanisms can eventually be conducted after identification of the critical GABAergic neurons. It should be kept in mind that other receptors and channels in addition to Nmdar receptors may also mediate the effects of ketamine in Sp4 hypomorphic mice (Jamie Sleigha, 2014) . In the future, restoration of the Sp4 gene in forebrain GABAergic neurons via temporal and regional-specific (e.g. cortex or striatum) control of Cremediated DNA recombination may clarify the role of development of GABAergic neurons and functions of regional GABAergic neurons in controlling locomotor responses to ketamine.
Abnormalities of cortical GABAergic neurons have been reported consistently in the postmortem brains from patients with schizophrenia (Lewis et al, 2005) . Ketamine produces schizophrenia-like behavioral phenotypes in healthy people and exacerbates symptoms in schizophrenia patients. Our studies suggest that SP4, deleted in some patients with schizophrenia, could be a missing piece that links a genetic susceptibility gene with ketamine hypersensitivity and abnormal function of GABAergic neurons in schizophrenia. The influence of the Sp4-GABAergic-ketamine pathway may not be limited to the regulation of locomotor activity in response to ketamine. Given that ketamine functions as a potent antidepressant, it will be interesting to investigate whether the Sp4-GABAergic-ketamine pathway may also be involved in the regulation of depressive behaviors. Indeed, our most recent studies suggested that Sp4 hypomorphic mice displayed depressive-like behaviors (Young et al., submitted) . In the future, such depressive-like phenotypes will be examined after ketamine treatment in Sp4 hypomorphic mice with restoration of the Sp4 gene in GABAergic neurons. Zhou X, Nie Z, Roberts A, Zhang D, Sebat J, Malhotra D, et al (2010) . Reduced NMDAR1 expression in the Sp4 hypomorphic mouse may contribute to endophenotypes of human psychiatric disorders. Hum Mol Genet 19(19) : 3797-3805. Zhou X, Qyang Y, Kelsoe JR, Masliah E, Geyer MA (2007) . Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice. Genes Brain Behav 6(3) : 269-276. Zhou X, Tang W, Greenwood TA, Guo S, He L, Geyer MA, et al (2009) . Transcription factor SP4 is a susceptibility gene for bipolar disorder. PLoS ONE 4(4): e5196. to confirm rat Sp4 RNA expression with one primer from mouse exon 1 and the other one from rat Sp4 gene (Zhou et al, 2005) . The presence of Emx1-Cre restored Sp4 expression in the cortex of the rescue mice (Sp4 Hypo/Hypo ; Emx1 +/+(Cre) ). Some expression of rat Sp4 in the striatum of the rescue mice likely comes from a few Emx1 expressing neurons. Prepulse inhibition was conducted in these mice. No sex effect was found. Sp4 hypomorphic mice displayed PPI deficits across three different levels of prepulse compared to wildtype mice regardless of the presence or absence of the Emx1-Cre gene. (b) All mice were habituated for 30 min before injection of ketamine (50 mg/kg). Injection of ketamine significantly increased locomotor activity in all 4 genotypes. However, there was a significantly larger increase of locomotor activity in Sp4 hypomorphic mice with or without the Emx1-Cre gene than in wildtype mice. There was no interaction between Sp4 X Emx1-Cre X Ketamine. Error bar: SEM WT carrying Dlx6a-Cre (Sp4 +/+ ; Tg(Dlx6a-Cre)), 21 rescue mice (Sp4 Hypo/Hypo ; Tg(Dlx6a-Cre)) for behavioral analyses. Our breeding generated fewer wildtype and Sp4 hypomorphic mice. More rescue mice and the control wildtype mice carrying the Dlx6a-Cre transgene were produced. (a)
Figure Legends
Prepulse inhibition was examined in all four genotypes of mice. There was no sex effect on PPI. Sp4 hypomorphic mice displayed PPI deficits across three different levels of prepulse compared to wildtype mice. No interaction between Sp4 X Dlx6a-Cre was observed. (b) After 30 min habituation in VT chamber, mice were injected with ketamine (50mg/kg). As expected, Sp4 hypomorphic mice displayed significant more locomotor activity after ketamine injection (F(1,85)=14.54, p < 0.001). Post hoc analysis revealed more distance traveled in the Sp4 hypomorphic mice than wildtype mice at 10 (* p < 0.05), 20 (** p < 0.01), 30 (** p < 0.01), 40 (** p < 0.01), and 50 min (* p < 0.05) post-ketamine injection. A significant Sp4 X Dlx6a-Cre X ketamine interaction was found (F(1,85)=7.44, p = 0.008). Post hoc analysis revealed significant differences in distance traveled between the Sp4 hypomorphic mice in the absence or presence (rescue) of the Dlx6a-Cre transgene at 20 ( ## p < 0.01), 30 ( ## p < 0.01), 40 ( ## p < 0.01) min post-ketamine injection. The rescue mice (Sp4 Hypo/Hypo ; Tg(Dlx6a-Cre) displayed no difference in locomotor activity from the wildtype mice carrying the Dlx6a-Cre gene, suggesting an almost complete rescue of the excessive response to ketamine. Error bar: SEM.
